Alpheus Medical
  • HOME
    • WHY WE DO IT
    • WHAT WE DO
    • HOW WE DO IT
  • NEWS
  • ABOUT US
    • COMPANY OVERVIEW
    • LEADERSHIP
    • INVESTORS
Select Page

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

RECENT NEWS

  • Alpheus Medical Announces Positive Phase 1/2 Trial Results November 24, 2024
  • First Treated Patient in First-In-Human Clinical Trial for Novel Brain Cancer Treatment November 10, 2022
  • FDA Grants Alpheus Medical Orphan Drug and Fast Track Designations July 13, 2022
  • Formation of Advisory Board to Support Development of Novel Brain Cancer Treatment March 2, 2022
  • Alpheus Medical closes $16m in Series A financing for novel glioma brain cancer treatment November 17, 2021

Designed by Elegant Themes | Powered by WordPress